Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeEXECUTIVESSOLIUS New World-class Talent and Scientific Leadership Team

SOLIUS New World-class Talent and Scientific Leadership Team

December 7, 2020

SOLIUS new world-class talent and scientific leadership team is led by technology and health care executive Bob Wise.

SOLIUS is focused on expanding its body of scientific validation through clinical trials, and recent additions to the medical advisory board align with this purpose. The company is working with leading experts in the fields of phototherapy and vitamin D research to develop its products and execute their trials.

The SOLIUS medical advisory board includes:

Dr. Ganesh Raghu from the University of Washington: Dr. Raghu is a board-certified physician at UW Medical Center, director of the UW Interstitial Lung Disease/Sarcoid/Pulmonary Fibrosis Program, and founder and former director of the UW Medicine Lung Transplant Program. He is board-certified in both Internal Medicine and Critical Care. Dr. Raghu’s 30+ years of research is devoted to both basic science (lung fibroblast and extracellular matrix) and translational and clinical studies in the field of pulmonary fibrosis, idiopathic interstitial pneumonia, and sarcoid.

Dr. Frank Lau from Louisiana State University: Dr. Lau is an Associate Professor of Clinical Surgery at LSU. He is the principal investigator of a tissue engineering and breast cancer research lab and is the recipient of 18 grants. His research interests include breast cancer, vitamin D insufficiency in COVID-19, incisional hernia prevention, pyoderma gangrenosum, regenerative approaches to limb salvage, and diseases of white adipose tissue.

Dr. Jan Dutz from the University of British Columbia: Dr. Dutz is a rheumatologist and dermatologist with a special clinical interest in the cutaneous manifestations of autoimmunity and rheumatic disease. His research focus is on the skin immune system and the manipulation of this system to promote immune responses and induce tolerance.

Dr. Michael Holick from Boston University: Dr. Holick is the Director of the General Clinical Research Unit, Bone Health Care Clinic, and Vitamin D, Skin and Bone Research Laboratory at Boston University. Dr. Holick has made numerous contributions to the field of the biochemistry, physiology, metabolism, and photobiology of vitamin D for human nutrition. He has established global recommendations advising sunlight exposure as an integral source of vitamin D and helped increase awareness in the medical community regarding the vitamin D deficiency pandemic, and its role not only in causing metabolic bone disease and osteoporosis but in an increased risk of developing multiple diseases.

On the executive team, the company has brought on Dr. Jashin Wu to serve as Chief Medical Officer. Dr. Wu is a dermatologist specializing in the treatment of psoriasis and is experienced in treating patients using light therapy. Dr. Wu is the founder and Course Director of the San Diego Dermatology Symposium and is the founder and CEO of the Dermatology Research and Education Foundation.

SOLIUS also added Rick White and Doug Hansmann to the board of directors. White served in the U.S. House of Representatives from 1995 to 1999, where he was known as one of Congress’s most active legislators on high-tech issues and is currently principal of the Woodbay Group where he focuses primarily on projects in the technology and public policy areas. Hansmann is a co-founder of EKOS Corporation and has been active as a bioengineer for several decades. He has a rich background in medical device product development and brings enormous expertise to the company.

Wise said, “Our team has never been more focused, and we are tremendously excited about the products we are developing and their impact on the health of everyone around us.”

View our full executive team, the board of directors, and medical advisory board here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy